blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4299722

EP4299722 - METHOD FOR INDUCING ANTIGEN-SPECIFIC T CELL AND USE THEREOF IN TREATING CANCER OR VIRUS INFECTION [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  01.12.2023
Database last updated on 25.09.2024
Most recent event   Tooltip05.07.2024Change - designated statespublished on 07.08.2024  [2024/32]
Applicant(s)For all designated states
Fullhope Biomedical Co., Ltd.
10F., No. 10, Ln. 609, Sec. 5, Chongxin Rd.
Sanchong Dist.
New Taipei City 24159 / TW
[2024/01]
Inventor(s)01 / LEE, Jan-Mou
24159 New Taipei City / TW
02 / FANG, Chih-Hao
24159 New Taipei City / TW
03 / CHENG, Ya-Fang
24159 New Taipei City / TW
 [2024/01]
Representative(s)Engelhard, Markus
Boehmert & Boehmert
Anwaltspartnerschaft mbB
Pettenkoferstrasse 22
80336 München / DE
[2024/01]
Application number, filing date23181205.823.06.2023
[2024/01]
Priority number, dateUS202263354868P23.06.2022         Original published format: US 202263354868 P
[2024/01]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP4299722
Date:03.01.2024
Language:EN
[2024/01]
Search report(s)(Supplementary) European search report - dispatched on:EP04.12.2023
ClassificationIPC:C12N5/0783
[2024/01]
CPC:
C12N5/0636 (EP,CN,US); A61K39/464838 (US); A61K39/0011 (CN);
A61K39/12 (EP,CN); A61K39/4611 (US); A61K39/464499 (US);
A61P31/12 (CN); A61P35/00 (CN); C12N5/0638 (EP);
A61K2039/5158 (CN); C12N2500/84 (CN); C12N2501/2302 (EP,CN,US);
C12N2501/2315 (EP,CN,US); C12N2501/24 (EP,CN,US); C12N2501/999 (CN);
C12N2506/11 (EP,US); C12N2710/16134 (EP); C12N2710/16234 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   ME,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2024/32]
Former [2024/01]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  ME,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
Extension statesBANot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:VERFAHREN ZUR INDUZIERUNG ANTIGENSPEZIFISCHER T-ZELLEN UND VERWENDUNG DAVON BEI DER BEHANDLUNG VON KREBS ODER VIRUSINFEKTIONEN[2024/01]
English:METHOD FOR INDUCING ANTIGEN-SPECIFIC T CELL AND USE THEREOF IN TREATING CANCER OR VIRUS INFECTION[2024/01]
French:PROCÉDÉ D'INDUCTION DE LYMPHOCYTES T SPÉCIFIQUES D'UN ANTIGÈNE ET SON UTILISATION DANS LE TRAITEMENT DU CANCER OU D'UNE INFECTION VIRALE[2024/01]
Examination procedure23.06.2023Examination requested  [2024/01]
03.07.2024Amendment by applicant (claims and/or description)
03.07.2024Date on which the examining division has become responsible
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO2019183924  (SYZ CELL THERAPY CO [CN], et al) [A] 3-6 * claims 1, 22; description para [092], [200-201] *;
 [XI]  - DI SCALA MARIANNA ET AL, "Complementary Effects of Interleukin-15 and Alpha Interferon Induce Immunity in Hepatitis B Virus Transgenic Mice", JOURNAL OF VIROLOGY, US, vol. 90, no. 19, doi:10.1128/JVI.01030-16, ISSN 0022-538X, (20160912), pages 8563 - 8574, URL: https://journals.asm.org/doi/pdf/10.1128/JVI.01030-16, (20231110), XP093100245 [X] 1,2,9,13-15 * Description page 3 right column para 1; page 8 right column para 2; Figure 8 * [I] 3-8,10-12

DOI:   http://dx.doi.org/10.1128/JVI.01030-16
 [A]  - XU HAO ET AL, "Influence of various medium environment to in vitro human T cell culture", IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY. ANIMAL., New York, vol. 54, no. 8, doi:10.1007/s11626-018-0273-3, ISSN 1071-2690, (20180712), pages 559 - 566, URL: https://link.springer.com/content/pdf/10.1007/s11626-018-0273-3.pdf, (20231110), XP093102500 [A] 11 * page 2 right column para 3-4; pg 3 right column para 1, page 4 right column para 1 *

DOI:   http://dx.doi.org/10.1007/s11626-018-0273-3
 [A]  - EMANUELE CANESTRARI ET AL, "Human Platelet Lysate Media Supplement Supports Lentiviral Transduction and Expansion of Human T Lymphocytes While Maintaining Memory Phenotype", JOURNAL OF IMMUNOLOGY RESEARCH, US, (20190904), vol. 2019, doi:10.1155/2019/3616120, ISSN 2314-8861, pages 1 - 11, XP055671229 [A] 12 * Introduction page 2 right column para 3; Results sections 3.2-3.4 *

DOI:   http://dx.doi.org/10.1155/2019/3616120
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.